Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 20 of 22 for “"Pharmaceutical intermediates"”.
-
BIOCATALYTIC SYNTHESIS OF CHIRAL PHARMACEUTICAL INTERMEDIATES
Questa Tesi di Dottorato è stata strutturata in due parti differenti precedute da un’introduzione riguardante i principi fondamentali della biocatalisi con particolare attenzione sull’applicazione di cellule intere di lieviti non convenzionali e una nuova chetoreduttasi proveniente dal lievito …
-
Water and carbon dioxide for sustainable synthesis and separation of pharmaceutical intermediates
… and processes for the sustainable production of pharmaceuticals. The first project was focused on the use of CO₂ to enhance Suzuki coupling reactions of substrates containing unprotected primary amines. This work established that exceptionally challenging substrates like halogenated amino …
-
Engineering of an efficient and enantioselevtive biocatalyst for the preparation of chiral pharmaceutical intermediates
… challenging reaction for the synthesis of chiral pharmaceutical intermediates. Our target enzyme is the novel P450pyr enzyme from Sphingomonas sp. HXN-200 that was found to catalyze the regio- and stereoselective hydroxylation of non-activated carbon atom with broad substrate range, high activity, …
-
Engineering of an efficient and enantioselective biocatalyst for the preparation of chiral pharmaceutical intermediates
… challenging reaction for the synthesis of chiral pharmaceutical intermediates. Our target enzyme is the novel P450pyr enzyme from Sphingomonas sp. HXN-200 that was found to catalyze the regio- and stereoselective hydroxylation of non-activated carbon atom with broad substrate range, high activity, …
-
The relationship between structure and specificity in the plant nitrilases
… important in the manufacture of fine chemicals, pharmaceutical intermediates, plastics and paints. Industrial uses of nitrilases are limited however, as wild-type enzymes suffer from limitations such as: a lack of control of the acid:amide ratio of products, and limited availability of substrate …
-
BIOPROCESS ENGINEERING FOR ENHANCING THE PRODUCTIVITY AND SELECTIVITY OF BIOOXIDATIONS
… MOLECULES THAT ARE VALUABLE FINE CHEMICALS AND PHARMACEUTICAL INTERMEDIATES. THE INHIBITION AND TOXICITY OF SUBSTRATE AND PRODUCT FORM CHALLENGES IN DEVELOPING EFFICIENT BIOOXIDATION PROCESSES. THIS THESIS AIMS TO ENGINEER BIPHASIC BIOCATALYTIC PROCESSES TO ENHANCE PRODUCTIVITY AND …
-
Biocatalysis in organic synthesis
… of the use of biocatalysis for the synthesis of pharmaceutical intermediates and natural products. This review focuses, in particular, on the impact of recent developments in technologies which enable the increased use of biocatalysts. These developments include: • the immobilisation of …
-
ENGINEERING OF HIGHLY ENANTIOSELECTIVE AND ACTIVE BIO-CATALYSTS FOR EFFICIENT ASYMMETRIC HYDROXYLATION
… useful reaction for the preparation of valuable pharmaceutical intermediates. However, the practical application of monooxygenases for the hydroxylation of non-natural substrates is often limited, due to the unsatisfied enantioselectivity, inefficient supply of the necessary co-factor, and narrow …
-
Coordinated Two-Stage Dynamic Deregulation of Central Metabolism Improves Malonyl-CoA Biosynthesis
… for a wide range of commercial products and pharmaceutical intermediates. In E. coli, malonyl-CoA levels are tightly regulated to remain at low levels. Two Stage Dynamic Metabolic Control (DMC) is a tool previously demonstrated to improve desired metabolite flux for several products. This …
-
The Synthesis and Biocatalytic Reduction of Beta-keto Alkynes
… community. They are employed as valuable pharmaceutical intermediates and are opportune to generate antiviral nucleoside analogues. Chiral inducement of these molecules thus far has been poor (low ee) and has constituted a key challenge for asymmetric synthesis in the last few decades. …
-
Σύνθεση φαρμακευτικών δραστικών ενώσεων με χρήση της χημείας συνεχούς ροής (flow chemistry)
… program, in collaboration with the pharmaceutical industry Pharmathen S.A. tested the use of continuous flow for the synthesis of pharmaceutical intermediates and final active substances with the aim of exploiting them by industry. Finally the fourth and last part deals with the …
-
Homogeneous hydrogenation and photochemistry as tools in pharmaceutical process development
… vessels more likely encountered within the pharmaceutical industry (< 10 bar of hydrogen pressure). Process understanding was obtained using an experimental design approach which was used to rationalise and suppress the formation of impurities. Mechanistic insight was also gathered using …
-
Structure Pharmaceutics Based on Synchrotron Radiation X-Ray Micro- Computed Tomography: From Characterization to Evaluation and Innovation of Pharmaceutical Structures
Drug delivery systems (DDS) are essentially pharmaceutical products for human therapy, typically involving a mixture of active ingredients and excipients. Based upon quantitative characterization of structure, the thesis introduces the concept of classifying the architecture of DDS into four levels …
-
OPPORTUNITIES AND CHALLENGES OF BIOCATALYSIS IN PHARMACEUTICAL SCIENCES: DEVELOPING TAILORED BIOCATALYSTS FOR SYNTHETIC APPLICATIONS
… in the preparation of stereochemically complex pharmaceutical intermediates. This doctoral research focuses on the development of tailored biocatalysts, specifically amine transaminases (ATAs), for the synthesis of pharmaceutically relevant compounds. To overcome typical limitations of wild-type …
-
Biotransformations of Proline by 2-oxoglutarate-dependent hydroxylases
… interest for use in the production of pharmaceutical intermediates and drug metabolites. 2-oxoglutarate dependent oxygenases (2OGDOs) are non-haem dependent Fe(II) containing enzymes that catalyse various oxidation reactions, including the hydroxylation of free amino acids. Unlike the …
-
Novel hybrid organic/inorganic single-sited catalysts and supports for fine chemical and pharmaceutical intermediate synthesis
… for the production of fine chemical and pharmaceutical intermediates.
-
Oxidation of Ketones: A (Chemo-) Enzymatic Approach Using Oxygenases and Hydrolases
… commonly used for the synthesis of chemicals and pharmaceuticals, however such processes have a number of limitations, they use chlorinated solvents, stoichiometric oxidation reagents, and in some cases the reagents that have risks of explosion during transportation and storage. This has called …
Page 1 of 2